Stroke prevention device misses key goal in study

by Marilynn Marchione

The future is unclear for a promising heart device aimed at preventing strokes in people at high risk of them because of an irregular heartbeat.

Early results from a key study of Boston Scientific Corp.'s Watchman device suggest it is safer than previous testing suggested, but may not be as good as a drug that is used now for preventing strokes, heart-related deaths and in people with atrial . That condition causes the heart to flutter rather than beat as it should, which can lead to clots that cause strokes.

The results were to have been the top study at an American College of Cardiology conference in San Francisco on Saturday but the presentation was pulled because the company released results early.

0 shares

Related Stories

Stroke-preventing technology demonstrated in JoVE

date Feb 28, 2012

In the United States alone, approximately 6 million people suffer from an irregular heartbeat called atrial fibrillation (AF), and since the incidence increases with age, it is predicted that 15.9 million ...

FDA clears anticlotting drug Eliquis

date Dec 28, 2012

The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes ...

Recommended for you

CDC: Hypertension-related deaths on the rise in US

date Mar 27, 2015

(HealthDay)—The overall death rate from high blood pressure in the United States has increased 23 percent since 2000, even as the death rate from all other causes has dropped 21 percent, health officials ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.